Mild cognitive impairment: disparity of incidence and prevalence estimates
- PMID: 22265588
- DOI: 10.1016/j.jalz.2011.01.002
Mild cognitive impairment: disparity of incidence and prevalence estimates
Abstract
Background: The purpose of conducting this study was to identify areas of concordance and sources of variation for the published rates of prevalence and incidence associated with various definitions for mild cognitive impairment (MCI).
Methods: The study used systematic review of studies published in English since 1984. Studies were identified by searching MEDLINE and EMBASE databases. Population-based observational studies of incidence or prevalence of MCI and related terms were eligible for inclusion.
Results: A total of 3,705 citations were identified, and 42 were accepted for inclusion; 35 included data on prevalence and 13 on incidence. The following four terms predominated: age-associated memory impairment (AAMI); cognitive impairment no dementia (CIND); MCI; and amnestic MCI (aMCI). Within each term, the operational definition varied. Substantial variation was observed for both incidence (MCI: 21.5-71.3; aMCI: 8.5-25.9 per 1,000 person-years) and prevalence of each definition of cognitive impairment (AAMI 3.6%-38.4%; CIND 5.1%-35.9%; MCI 3%-42%; aMCI 0.5%-31.9%). CIND and MCI showed increasing prevalence among older age groups, whereas age-specific rates of aMCI were lower and without any apparent age relationship.
Conclusions: Prevalence and incidence estimates associated with MCI vary greatly both between definitions and within a definition across the 42 publications. These wide differences pose a significant challenge to our understanding of the social burden of this disease. Enhancement and standardization of operational definitions of the subtypes of cognitive impairment could improve estimates of disease burden and provide a mechanism to assist in the identification of individuals at risk for future Alzheimer's disease and other dementias.
Copyright © 2012 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159. Cochrane Database Syst Rev. 2001. PMID: 11687175 Free PMC article.
-
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2. Cochrane Database Syst Rev. 2017. PMID: 28328043 Free PMC article.
-
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2. Cochrane Database Syst Rev. 2017. PMID: 29164603 Free PMC article.
-
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884. Cochrane Database Syst Rev. 2017. PMID: 29164602 Free PMC article.
-
Vitamin E for Alzheimer's dementia and mild cognitive impairment.Cochrane Database Syst Rev. 2017 Apr 18;4(4):CD002854. doi: 10.1002/14651858.CD002854.pub5. Cochrane Database Syst Rev. 2017. PMID: 28418065 Free PMC article.
Cited by
-
White matter changes in patients with amnestic mild cognitive impairment detected by diffusion tensor imaging.PLoS One. 2013;8(3):e59440. doi: 10.1371/journal.pone.0059440. Epub 2013 Mar 21. PLoS One. 2013. PMID: 23555673 Free PMC article.
-
Identification of the Potential Key Circular RNAs in Elderly Patients With Postoperative Cognitive Dysfunction.Front Aging Neurosci. 2020 Jun 23;12:165. doi: 10.3389/fnagi.2020.00165. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32655392 Free PMC article.
-
Validation of a novel computerized cognitive function test for the rapid detection of mild cognitive impairment.BMC Neurol. 2022 Dec 7;22(1):457. doi: 10.1186/s12883-022-02997-4. BMC Neurol. 2022. PMID: 36476188 Free PMC article.
-
Association between 24-h urinary sodium to potassium ratio and mild cognitive impairment in community-based general population.Public Health Nutr. 2021 Dec;24(17):5795-5804. doi: 10.1017/S1368980021001452. Epub 2021 Apr 6. Public Health Nutr. 2021. PMID: 33821782 Free PMC article.
-
Risk of conversion from mild cognitive impairment to dementia in low- and middle-income countries: A systematic review and meta-analysis.Alzheimers Dement (N Y). 2022 Mar 13;8(1):e12267. doi: 10.1002/trc2.12267. eCollection 2022. Alzheimers Dement (N Y). 2022. PMID: 35310524 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources